Pu Xuan
Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival
Xuan, Pu; Storr, Sarah J.; Zhang, Yimin; Rakha, Emad; Green, Andrew R.; Ellis, Ian O.; Martin, Stewart G.
Authors
Sarah J. Storr
Yimin Zhang
Professor EMAD RAKHA Emad.Rakha@nottingham.ac.uk
PROFESSOR OF BREAST CANCER PATHOLOGY
Andrew R. Green
Ian O. Ellis
Stewart G. Martin
Abstract
Impaired apoptosis is one of the hallmarks of cancer. Caspase-3 and -8 are key regulators of the apoptotic response and have been shown to interact with the calpain family, a group of cysteine proteases, during tumorigenesis. The current study sought to investigate the prognostic potential of caspase-3 and -8 in breast cancer, as well as the prognostic value of combinatorial caspase and calpain expression. A large cohort (n = 1902) of early stage invasive breast cancer patients was used to explore the expression of caspase-3 and -8. Protein expression was examined using standard immunohistochemistry on tissue microarrays. High caspase-3 expression, but not caspase-8, is significantly associated with adverse breast cancer-specific survival (P = 0.008 and P = 0.056, respectively). Multivariate analysis showed that caspase-3 remained an independent factor when confounding factors were included (hazard ratio (HR) 1.347, 95% confidence interval (CI) 1.086–1.670; P = 0.007). The analyses in individual subgroups demonstrated the significance of caspase-3 expression in clinical outcomes in receptor positive (ER, PR or HER2) subgroups (P = 0.001) and in non-basal like subgroup (P = 0.029). Calpain expression had been previously assessed. Significant association was also found between high caspase-3/high calpain-1 and breast cancer-specific survival in the total patient cohort (P = 0.005) and basal-like subgroup (P = 0.034), as indicated by Kaplan–Meier analysis. Caspase-3 expression is associated with adverse breast cancer-specific survival in breast cancer patients, and provides additional prognostic values in distinct phenotypes. Combinatorial caspase and calpain expression can predict worse prognosis, especially in basal-like phenotypes. The findings warrant further validation studies in independent multi-centre patient cohorts.
Citation
Xuan, P., Storr, S. J., Zhang, Y., Rakha, E., Green, A. R., Ellis, I. O., & Martin, S. G. (in press). Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival. Apoptosis, https://doi.org/10.1007/s10495-016-1323-5
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 25, 2016 |
Online Publication Date | Oct 31, 2016 |
Deposit Date | Jan 12, 2017 |
Publicly Available Date | Jan 12, 2017 |
Journal | Apoptosis |
Print ISSN | 1360-8185 |
Electronic ISSN | 1573-675X |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1007/s10495-016-1323-5 |
Keywords | Breast cancer, Caspase, Calpain, Breast cancer-specific survival, Biomarker |
Public URL | https://nottingham-repository.worktribe.com/output/820939 |
Publisher URL | http://link.springer.com/article/10.1007%2Fs10495-016-1323-5 |
Contract Date | Jan 12, 2017 |
Files
art%3A10.1007%2Fs10495-016-1323-5.pdf
(1.6 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Simply-supported multi-layered beams for energy harvesting
(2016)
Journal Article
The role of the ALKBH5 RNA demethylase in invasive breast cancer
(2024)
Journal Article
Epitranscriptomic mechanisms of androgen signalling and prostate cancer
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search